菲律宾帕金森病脑深部电刺激:菲律宾运动障碍外科中心的结果
该回顾性研究纳入2006至2016年在菲律宾运动障碍外科中心接受脑深部电刺激(DBS)的全部帕金森病(PD)患者17例,评估统一帕金森病评定量表(UPDRS)运动评分与左旋多巴等效剂量变化。结果显示服药关期与开期UPDRS运动评分均有统计学显著下降,至随访第2年PD药物剂量显著减少52.3%(P < 0.001),不良事件包括一次自杀未遂和一次装置相关感染。
要点
- 服药关期UPDRS运动评分在DBS后3个月下降48.2%(P = 0.004)、1年下降47.3%(P = 0.026)、2年下降48.4%(P = 0.021)、3年下降66.0%(P = 0.032)。
- 服药开期UPDRS运动评分在3个月下降43.3%(P = 0.023)、6个月下降24.7%(P = 0.053)、1年下降38.1%(P = 0.033)。
- 至随访第2年PD药物剂量显著减少52.3%(P < 0.001),不良事件包括一次自杀未遂和一次装置相关感染。
核心结论
- DBS可改善PD患者服药关期与开期的UPDRS运动评分,最大获益见于术后3年,并使PD药物剂量减半。
- 作者认为DBS的获益不可否认,但手术费用高昂使更多患者无法受益,需要政府支持以扩大DBS的可及性。
研究设计与样本
- 回顾性研究,纳入2006年至2016年在菲律宾运动障碍外科中心接受DBS的全部PD患者17例。
- 评估UPDRS运动评分与左旋多巴等效剂量的变化。
主要发现
- 服药关期UPDRS运动评分在DBS后3个月下降48.2%(P = 0.004)、1年下降47.3%(P = 0.026)、2年下降48.4%(P = 0.021)、3年下降66.0%(P = 0.032)。
- 服药开期UPDRS运动评分在3个月下降43.3%(P = 0.023)、6个月下降24.7%(P = 0.053)、1年下降38.1%(P = 0.033)。
- 至随访第2年PD药物剂量显著减少52.3%(P < 0.001)。
- 不良事件包括一次自杀未遂和一次装置相关感染。
临床怎么用
- 原文结论未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Deep brain stimulation (DBS) is an established treatment modality for Parkinson disease (PD). The first DBS for PD in the Philippines was performed at the Philippine Movement Disorder Surgery Center in 2006. There are no Philippine data on DBS for PD. We aim to determine the motor improvement and reduction in medication dosage of all patients with PD who underwent DBS at the Philippine Movement Disorder Surgery Center. METHODS: This is a retrospective study of all patients with PD (n = 17) who underwent DBS from 2006 to 2016. The change in the Unified Parkinson's Disease Rating Scale (UPDRS) motor and levodopa equivalent dose were determined. RESULTS: There was a statistically significant reduction in the UPDRS motor in all patients off medication at 3 months (48.2%; P = 0.004), 1 year (47.3%; P = 0.026), 2 years (48.4%; P = 0.021), and 3 years (66.0%; P = 0.032) after DBS and on medication at 3 months (43.3%; P = 0.023), 6 months (24.7%; P = 0.053), and 1 year (38.1%; P = 0.033). A significant reduction in the dosage of PD medications was also seen until the second year of follow-up (52.3%; P < 0.001). Adverse events included an attempted suicide and a device-related infection. CONCLUSIONS: DBS for PD improves the UPDRS motor score in the off-medication and on-medication state, with the maximal benefit seen at 3 years after surgery and reduces PD medication dosage by half. Although the benefit from DBS is undeniable, the high cost of the procedure precludes more patients from benefitting from it. There is a need for government support to expand access to DBS.
引用
- Diestro JDB, Vesagas TS, Teleg RA, et al. Deep Brain Stimulation for Parkinson Disease in the Philippines: Outcomes of the Philippine Movement Disorder Surgery Center. World Neurosurg. 2018. PMID: 29709756. doi:10.1016/j.wneu.2018.04.125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。